Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
Apolipoprotein (apo)C-I and apoC-III are constituents of HDL and of triglyceride-rich lipoproteins that slow the clearance of triglyceride-rich lipoproteins by a variety of mechanisms. ApoC-I is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor....
Gespeichert in:
Veröffentlicht in: | Current opinion in lipidology 2001-06, Vol.12 (3), p.297-304 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 304 |
---|---|
container_issue | 3 |
container_start_page | 297 |
container_title | Current opinion in lipidology |
container_volume | 12 |
creator | Shachter, N S |
description | Apolipoprotein (apo)C-I and apoC-III are constituents of HDL and of triglyceride-rich lipoproteins that slow the clearance of triglyceride-rich lipoproteins by a variety of mechanisms. ApoC-I is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. It also is the major plasma inhibitor of cholesteryl ester transfer protein, and appears to interfere directly with fatty acid uptake. ApoC-III also interferes with lipoprotein particle clearance, but its principal role is as an inhibitor of lipolysis, both through the biochemical inhibition of lipoprotein lipase and by interfering with lipoprotein binding to the cell-surface glycosaminoglycan matrix where lipolytic enzymes and lipoprotein receptors reside. Variation in the expression of apoC-III has been credibly documented to have an important role in hypertriglyceridemia. Variation in the expression of apoC-I may also be important for hypertriglyceridemia under certain circumstances. |
doi_str_mv | 10.1097/00041433-200106000-00009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70846471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70846471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c377t-2779dc4b1cc5c5c8d0f2860c85082fc09f2e8d7048139c45646c46e85decbe5c3</originalsourceid><addsrcrecordid>eNpNkEtPwzAMx3MAsTH4CignbgHn0TyO0wRs0qRd4BylaSoVtU1p2gPfnoyNhy3LjuK_bf0QwhQeKBj1CACCCs4JA6Ag85PkAHOBlmAKRYxUbIGuU3rP_8yAukILSnnBsy3RYT3EthniMMYpNH3CG7LDrq-OeZerhJtuiOPk-gl3sZpbN8Ux4VjjfyrchcmVeU7qbtBl7doUbs95hd6en143W7I_vOw26z3xXKmJMKVM5UVJvS-y6wpqpiV4XYBmtQdTs6ArBUJTbrwopJBeyKCLKvgyFJ6v0P1pbj7hYw5psl2TfGhb14c4J6tACykUzY361OjHmNIYajuMTefGT0vBHgHaH4D2F6D9Bpild-cdc9mF6k94pse_ACXSbVI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70846471</pqid></control><display><type>article</type><title>Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Shachter, N S</creator><creatorcontrib>Shachter, N S</creatorcontrib><description>Apolipoprotein (apo)C-I and apoC-III are constituents of HDL and of triglyceride-rich lipoproteins that slow the clearance of triglyceride-rich lipoproteins by a variety of mechanisms. ApoC-I is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. It also is the major plasma inhibitor of cholesteryl ester transfer protein, and appears to interfere directly with fatty acid uptake. ApoC-III also interferes with lipoprotein particle clearance, but its principal role is as an inhibitor of lipolysis, both through the biochemical inhibition of lipoprotein lipase and by interfering with lipoprotein binding to the cell-surface glycosaminoglycan matrix where lipolytic enzymes and lipoprotein receptors reside. Variation in the expression of apoC-III has been credibly documented to have an important role in hypertriglyceridemia. Variation in the expression of apoC-I may also be important for hypertriglyceridemia under certain circumstances.</description><identifier>ISSN: 0957-9672</identifier><identifier>DOI: 10.1097/00041433-200106000-00009</identifier><identifier>PMID: 11353333</identifier><language>eng</language><publisher>England</publisher><subject>Alleles ; Animals ; Apolipoprotein C-I ; Apolipoprotein C-III ; Apolipoproteins C - genetics ; Apolipoproteins C - physiology ; Gene Expression Regulation ; Genetic Variation ; Humans ; Hypertriglyceridemia - metabolism ; Lipoproteins - metabolism ; Low Density Lipoprotein Receptor-Related Protein-1 ; Mice ; Receptors, Immunologic - metabolism ; Receptors, LDL - metabolism</subject><ispartof>Current opinion in lipidology, 2001-06, Vol.12 (3), p.297-304</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c377t-2779dc4b1cc5c5c8d0f2860c85082fc09f2e8d7048139c45646c46e85decbe5c3</citedby><cites>FETCH-LOGICAL-c377t-2779dc4b1cc5c5c8d0f2860c85082fc09f2e8d7048139c45646c46e85decbe5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11353333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shachter, N S</creatorcontrib><title>Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism</title><title>Current opinion in lipidology</title><addtitle>Curr Opin Lipidol</addtitle><description>Apolipoprotein (apo)C-I and apoC-III are constituents of HDL and of triglyceride-rich lipoproteins that slow the clearance of triglyceride-rich lipoproteins by a variety of mechanisms. ApoC-I is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. It also is the major plasma inhibitor of cholesteryl ester transfer protein, and appears to interfere directly with fatty acid uptake. ApoC-III also interferes with lipoprotein particle clearance, but its principal role is as an inhibitor of lipolysis, both through the biochemical inhibition of lipoprotein lipase and by interfering with lipoprotein binding to the cell-surface glycosaminoglycan matrix where lipolytic enzymes and lipoprotein receptors reside. Variation in the expression of apoC-III has been credibly documented to have an important role in hypertriglyceridemia. Variation in the expression of apoC-I may also be important for hypertriglyceridemia under certain circumstances.</description><subject>Alleles</subject><subject>Animals</subject><subject>Apolipoprotein C-I</subject><subject>Apolipoprotein C-III</subject><subject>Apolipoproteins C - genetics</subject><subject>Apolipoproteins C - physiology</subject><subject>Gene Expression Regulation</subject><subject>Genetic Variation</subject><subject>Humans</subject><subject>Hypertriglyceridemia - metabolism</subject><subject>Lipoproteins - metabolism</subject><subject>Low Density Lipoprotein Receptor-Related Protein-1</subject><subject>Mice</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Receptors, LDL - metabolism</subject><issn>0957-9672</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEtPwzAMx3MAsTH4CignbgHn0TyO0wRs0qRd4BylaSoVtU1p2gPfnoyNhy3LjuK_bf0QwhQeKBj1CACCCs4JA6Ag85PkAHOBlmAKRYxUbIGuU3rP_8yAukILSnnBsy3RYT3EthniMMYpNH3CG7LDrq-OeZerhJtuiOPk-gl3sZpbN8Ux4VjjfyrchcmVeU7qbtBl7doUbs95hd6en143W7I_vOw26z3xXKmJMKVM5UVJvS-y6wpqpiV4XYBmtQdTs6ArBUJTbrwopJBeyKCLKvgyFJ6v0P1pbj7hYw5psl2TfGhb14c4J6tACykUzY361OjHmNIYajuMTefGT0vBHgHaH4D2F6D9Bpild-cdc9mF6k94pse_ACXSbVI</recordid><startdate>20010601</startdate><enddate>20010601</enddate><creator>Shachter, N S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010601</creationdate><title>Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism</title><author>Shachter, N S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c377t-2779dc4b1cc5c5c8d0f2860c85082fc09f2e8d7048139c45646c46e85decbe5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Alleles</topic><topic>Animals</topic><topic>Apolipoprotein C-I</topic><topic>Apolipoprotein C-III</topic><topic>Apolipoproteins C - genetics</topic><topic>Apolipoproteins C - physiology</topic><topic>Gene Expression Regulation</topic><topic>Genetic Variation</topic><topic>Humans</topic><topic>Hypertriglyceridemia - metabolism</topic><topic>Lipoproteins - metabolism</topic><topic>Low Density Lipoprotein Receptor-Related Protein-1</topic><topic>Mice</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Receptors, LDL - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shachter, N S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in lipidology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shachter, N S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism</atitle><jtitle>Current opinion in lipidology</jtitle><addtitle>Curr Opin Lipidol</addtitle><date>2001-06-01</date><risdate>2001</risdate><volume>12</volume><issue>3</issue><spage>297</spage><epage>304</epage><pages>297-304</pages><issn>0957-9672</issn><abstract>Apolipoprotein (apo)C-I and apoC-III are constituents of HDL and of triglyceride-rich lipoproteins that slow the clearance of triglyceride-rich lipoproteins by a variety of mechanisms. ApoC-I is an inhibitor of lipoprotein binding to the LDL receptor, LDL receptor-related protein, and VLDL receptor. It also is the major plasma inhibitor of cholesteryl ester transfer protein, and appears to interfere directly with fatty acid uptake. ApoC-III also interferes with lipoprotein particle clearance, but its principal role is as an inhibitor of lipolysis, both through the biochemical inhibition of lipoprotein lipase and by interfering with lipoprotein binding to the cell-surface glycosaminoglycan matrix where lipolytic enzymes and lipoprotein receptors reside. Variation in the expression of apoC-III has been credibly documented to have an important role in hypertriglyceridemia. Variation in the expression of apoC-I may also be important for hypertriglyceridemia under certain circumstances.</abstract><cop>England</cop><pmid>11353333</pmid><doi>10.1097/00041433-200106000-00009</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0957-9672 |
ispartof | Current opinion in lipidology, 2001-06, Vol.12 (3), p.297-304 |
issn | 0957-9672 |
language | eng |
recordid | cdi_proquest_miscellaneous_70846471 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Alleles Animals Apolipoprotein C-I Apolipoprotein C-III Apolipoproteins C - genetics Apolipoproteins C - physiology Gene Expression Regulation Genetic Variation Humans Hypertriglyceridemia - metabolism Lipoproteins - metabolism Low Density Lipoprotein Receptor-Related Protein-1 Mice Receptors, Immunologic - metabolism Receptors, LDL - metabolism |
title | Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A14%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Apolipoproteins%20C-I%20and%20C-III%20as%20important%20modulators%20of%20lipoprotein%20metabolism&rft.jtitle=Current%20opinion%20in%20lipidology&rft.au=Shachter,%20N%20S&rft.date=2001-06-01&rft.volume=12&rft.issue=3&rft.spage=297&rft.epage=304&rft.pages=297-304&rft.issn=0957-9672&rft_id=info:doi/10.1097/00041433-200106000-00009&rft_dat=%3Cproquest_cross%3E70846471%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70846471&rft_id=info:pmid/11353333&rfr_iscdi=true |